Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial (Q39203869)
Jump to navigation
Jump to search
scientific article published on 4 November 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial |
scientific article published on 4 November 2016 |
Statements
1 reference
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial (English)
1 reference
Shingo Matsumoto
1 reference
Kiyotaka Yoh
1 reference
Koichi Goto
1 reference
Katsuya Tsuchihara
1 reference
Takashi Kohno
1 reference
Genichiro Ishii
1 reference
Atsushi Ohtsu
1 reference
Takashi Seto
1 reference
Miyako Satouchi
1 reference
Makoto Nishio
1 reference
Noboru Yamamoto
1 reference
Haruyasu Murakami
1 reference
Naoyuki Nogami
1 reference
Koji Tsuta
1 reference
Shogo Nomura
1 reference
Akihiro Sato
1 reference
Yuichiro Ohe
1 reference
4 November 2016
1 reference
1 reference
5
1 reference
1
1 reference
42-50
1 reference
Identifiers
1 reference
1 reference